Johnson & Johnson

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Johnson & Johnson
May 18, 2025, 00:59 | Blog
Lisa A. Lacasse: We Must Accelerate Access to Cancer Screening and Early Detection
Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), shared…
May 13, 2025, 11:12 | Blog
Mahadi Baig: Honored to Start a Position as Vice President, Head of Solid Tumors at Johnson and Johnson
Mahadi Baig, Vice President, Head of Solid Tumors, US Medical Affairs at Johnson and Johnson,…
Apr 26, 2025, 10:18 | Blog
Renowned Leader William N. Hait Appointed as Chief Scientific Advisor of the AACR
On April 23, 2025, The American Association for Cancer Research (AACR) announced the appointment of…
Feb 8, 2025, 07:20 | Blog
Antonio Passaro: Honored to host the 20th International Preceptorship on Lung Cancer at IEO
Antonio Passaro, Medical Oncologist and a Medical Director at the European Institute of Oncology in…
Jan 17, 2025, 13:12 | Career
Danielle Blake was appointed as Director of Global Oncology Communications, GU and Public Affairs for Johnson and Johnson
Danielle Blake, Director of Global Oncology Communications, GU and Public Affairs at Johnson & Johnson…
Dec 17, 2024, 16:18 | Insight
Update on U.S. Regulatory Review of Subcutaneous Amivantamab
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has issued a…
Dec 15, 2024, 09:17 | Blog
Medicaid Cancer Foundation and Johnson & Johnson partner with NHIA to drive prostate cancer awareness and screening
Medicaid Cancer Foundation posted the following on LinkedIn: “Medicaid Cancer Foundation and Johnson & Johnson…
Nov 13, 2024, 10:52 | Blog
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO/DARZALEX…
Jul 7, 2024, 18:19 | Insight
Shahrin Ahmed: Efficacy of CARVYKTI in multiple myeloma
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "The Phase III…
Jun 21, 2024, 13:43 | Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Mar 11, 2024, 00:11 | Career
Mary Kate Weber: I've stepped into the role of Associate Director, Patient and Caregiver Solutions - Oncology within the PECS organization at Johnson & Johnson!
Mary Kate Weber, Associate Director, Patient & Caregiver Solutions - Oncology at Johnson & Johnson,…
Nov 9, 2023, 18:59 | Drugs
Najat Khan: Lots of buzz about the future of drug discovery
Najat Khan, Chief Data Science Officer & SVP/Global Head at Johnson & Johnson, made the…
Oct 7, 2023, 19:42 | Blog
Najat Khan: The results of the world’s largest blood biomarker study have been published in Nature, opening up new possibilities for scientific research.
Najat Khan, Chief Data Science Officer & SVP/Global Head, Strategy, Portfolio, Ops, R&D, J&J at…
Sep 15, 2023, 18:40 | Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
All: 14 Posts: 1 - 100
Special Coverage